Annals of Bone Marrow Research Submit Manuscript

    Using recombinant human G-CSF to treat chemotherapy-induced neutropenia over 3 decades: What is next?

    DOI Logo 10.17352/abmr.000010

    Published On: September 12, 2023 | Pages: 001 - 004

    Author(s): Jason Xu, Jonathan Sussman, Jessica Xu, Xing Zhao and Xiao Qiang Yan*
    Chemotherapy-Induced Neutropenia (CIN) is a potentially fatal side effect of cancer treatment, affecting > 50% of cancer patients treated with chemotherapy. Clinical use of recombinant human granulocyte colony-stimulating factor (rhG-CSF) has allowed for primary and secondary prophylaxis of CIN and its sequela (i.e., febrile neutropenia, fatal infection) during myelos ... CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat
    Abstract View Full Article View



    Case Reports

    Help ? Google Reviews 11